California State Teachers Retirement System (CalSTRS)’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,183
Closed -$23K 3187
2023
Q1
$23K Sell
10,183
-751
-7% -$2.59K ﹤0.01% 2971
2022
Q4
$38.2K Sell
10,934
-19,237
-64% -$169K ﹤0.01% 2949
2022
Q3
$1.12M Buy
30,171
+1,664
+6% +$46.1K ﹤0.01% 1824
2022
Q2
$541K Sell
28,507
-2,715
-9% -$59.2K ﹤0.01% 2353
2022
Q1
$843K Buy
31,222
+2,856
+10% +$59.1K ﹤0.01% 2136
2021
Q4
$639K Buy
28,366
+10,710
+61% +$238K ﹤0.01% 2423
2021
Q3
$463K Sell
17,656
-3,068
-15% -$82.1K ﹤0.01% 2481
2021
Q2
$663K Sell
20,724
-1,380
-6% -$47.9K ﹤0.01% 2478
2021
Q1
$778K Sell
22,104
-26
-0.1% -$909 ﹤0.01% 2295
2020
Q4
$710K Buy
22,130
+298
+1% +$10.2K ﹤0.01% 2232
2020
Q3
$821K Buy
21,832
+634
+3% +$24.5K ﹤0.01% 1978
2020
Q2
$949K Buy
+21,198
New +$896K ﹤0.01% 1875

Other funds holding RLMD

California State Teachers Retirement System (CalSTRS)'s RLMD Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of Relmada Therapeutics (RLMD) in Q2 2023, closing a stake of 10,183 shares — an estimated $23K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in RLMD in Q2 2020 and held it in 12 quarters. The position peaked at $1.12M in Q3 2022. 95 funds tracked by Wall St. Rank hold RLMD as of Q2 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Relmada Therapeutics position as of Q2 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 10,183 Relmada Therapeutics shares in Q2 2023, an estimated $23K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Relmada Therapeutics in Q2 2020 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Relmada Therapeutics position peaked at $1.12M in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.